SCHEMBL17127328

SCHEMBL17127328

CCOCCSC(C(=O)c1ccc(Oc2ccc3cc(OC)ccc3c2)c2ccccc12)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 1/20 0.37
▸ CNR1 P21554 2/20 0.35
▸ CNR2 P34972 2/20 0.35
▸ AURKA O14965 3/20 0.35
▸ MET P08581 3/20 0.35
▸ KDR P35968 3/20 0.35
▸ TEK Q02763 3/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ APP P05067 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ AKR1C3 P42330 3/20 0.34
▸ AKR1C2 P52895 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ AKR1C1 Q04828 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126861 0.95 CNR1 (0.39) CDC25BCNR1CNR2AURKAMET
SCHEMBL17127330 0.91 CNR1 (0.41) CNR1CNR2KDM4ELMNAMAPT
SCHEMBL17126857 0.91 APP (0.36) CDC25BAPPKDM4EPOLBMEN1
SCHEMBL17127331 0.90 CNR2 (0.42) CNR1CNR2FFAR1
SCHEMBL17127352 0.88 FFAR1 (0.39) CDC25BCNR1CNR2KDM4EMEN1
SCHEMBL17127350 0.86 HIF1A (0.39) APPMEN1KMT2AAKR1C3AKR1C2
SCHEMBL17126858 0.85 CNR1 (0.41) CNR1CNR2LMNAMAPTNPSR1
SCHEMBL17126865 0.82 CNR1 (0.41) CNR1CNR2POLBMEN1KMT2A
SCHEMBL17127353 0.81 HIF1A (0.40) APPKDM4EMEN1KMT2AAKR1C3
SCHEMBL17126862 0.81 AKR1C3 (0.39) KDM4EAKR1C3AKR1C2LMNAAKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS CDC25B 4520/4885CNR1 4336/4885CNR2 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback